NLRP3 and COVID-19: A potential activator of NLRP3 is reactive oxygen species (ROS), so it is thought that their excessive production resulting from inflammation in COVID-19 leads to NLRP3 activation and cleavage of the IL-1β precursor which potentiates inflammation [106].